ED
SPLS

Exane Derivatives’s Staples Inc SPLS Stock Holding History

Exane Derivatives’s Portfolio SPLS Stock Details SPLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10
Closed -$101 – 677
2017
Q2 		$101 Sell
10
-5,300
-100% -$49.5K ﹤0.01% 567
2017
Q1 		$46.6K Buy
+5,310
New +$47.9K 0.01% 273

Other funds holding SPLS

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
RCM
Radnor Capital Management Wayne, Pennsylvania $712M AUM 34.39% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Exane Derivatives's SPLS Position: Q3 2017 in Review

Exane Derivatives sold out of Staples Inc (SPLS) in Q3 2017, closing a stake of 10 shares — an estimated $101 sold.

Exane Derivatives first reported a position in SPLS in Q1 2017 and held it in 2 quarters. The position peaked at $46.6K in Q1 2017. 4 funds tracked by Wall St. Rank hold SPLS as of Q3 2017.

  • Exane Derivatives reported no remaining Staples Inc position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 10 Staples Inc shares in Q3 2017, an estimated $101.
  • Exane Derivatives first reported a position in Staples Inc in Q1 2017 and held it in 2 quarters.
  • Exane Derivatives's Staples Inc position peaked at $46.6K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Staples Inc as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.